Abstract: The present invention relates to nucleic acid molecules encoding a recombinant human cytomegalovirus (HCMV) strain, dense bodies produced by said HCMV strain and preparations of said dense bodies for use in medicine, particularly as a vaccine against HCMV.
Type:
Grant
Filed:
June 28, 2019
Date of Patent:
February 28, 2023
Assignee:
Universitätsmedizin der Johannes Gutenberg-Univsersität Mainz